When you enter multiple keywords separated by space, your search will contain results that match any of the keywords (OR search).
  • 28 Hits
  • Search Condition : Filter (MeSH = Carcinoma, Hepatocellular / drug therapy*)
Species Resource
DNA material pCAG-HIVgp (RDB04394) , pCMV-VSV-G-RSV-Rev (RDB04393) 3β-hydroxysterol δ24-reductase on the surface of hepatitis C virus-related hepatocellular carcinoma cells can be a target for molecular targeting therapy.
Human and Animal Cells Hep G2(RCB1886) , HuH-7(RCB1942) Prolonged inhibition of hepatocellular carcinoma cell proliferation by combinatorial expression of defined transcription factors.
Human and Animal Cells HepG2 , HuH-7 In vitro modeling of hepatocellular carcinoma molecular subtypes for anti-cancer drug assessment.
Human and Animal Cells HCT116(RCB2979) High expression of CD44v9 and xCT in chemoresistant hepatocellular carcinoma: Potential targets by sulfasalazine.
Human and Animal Cells COS-7(RCB0539) An Alkynyl-Fucose Halts Hepatoma Cell Migration and Invasion by Inhibiting GDP-Fucose-Synthesizing Enzyme FX, TSTA3.
Human and Animal Cells Additive effect of sirolimus and anti-death receptor 5 agonistic antibody against hepatocellular carcinoma.
Human and Animal Cells Combining celecoxib with sorafenib synergistically inhibits hepatocellular carcinoma cells in vitro.
Human and Animal Cells Sorafenib and TRAIL have synergistic effect on hepatocellular carcinoma.
Human and Animal Cells BMP4 administration induces differentiation of CD133+ hepatic cancer stem cells, blocking their contributions to hepatocellular carcinoma.
Human and Animal Cells Anticancer effects of residual powder from Barley-Shochu distillation remnants against the orthotopic xenograft mouse models of hepatocellular carcinoma in vivo.
Human and Animal Cells Erlotinib and sorafenib in an orthotopic rat model of hepatocellular carcinoma.
Human and Animal Cells Activation of JNK and high expression level of CD133 predict a poor response to sorafenib in hepatocellular carcinoma.
Human and Animal Cells The Rho kinase inhibitor fasudil is involved in p53-mediated apoptosis in human hepatocellular carcinoma cells.
Human and Animal Cells Caffeine increases the antitumor effect of Cisplatin in human hepatocellular carcinoma cells.
Human and Animal Cells Combination therapy for hepatocellular carcinoma: additive preclinical efficacy of the HDAC inhibitor panobinostat with sorafenib.
Human and Animal Cells Comparative analysis of cell death induction by cisplatin and 5-FU in human oral squamous and hepatocellular carcinoma cell lines.
Human and Animal Cells Irinotecan activates p53 with its active metabolite, resulting in human hepatocellular carcinoma apoptosis.
Human and Animal Cells Acyclic retinoid inhibits human hepatoma cell growth by suppressing fibroblast growth factor-mediated signaling pathways.
Human and Animal Cells Antitumor effects of saikosaponins, baicalin and baicalein on human hepatoma cell lines.
Human and Animal Cells Evaluation of ERCC1 expression for cisplatin sensitivity in human hepatocellular carcinoma.